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OBJECTIVES Our purpose was to determine the safety and accuracy of immediate exercise testing in
low-risk patients presenting to the emergency department (ED) with chest pain suggestive of
a cardiac etiology.
BACKGROUND Safe, efficient management of low-risk patients presenting to the ED with chest pain is a
continuing challenge. We have employed immediate exercise testing to evaluate a large,
heterogeneous group of low-risk patients presenting with chest pain.
METHODS Patients presenting to the ED with chest pain compatible with a cardiac origin and clinical
evidence of low risk on initial assessment underwent immediate exercise treadmill testing in
our chest pain evaluation unit. Indicators of low clinical risk included no evidence of
hemodynamic instability, arrhythmias or electrocardiographic signs of ischemia. Serial
measurements of cardiac injury markers were not obtained.
RESULTS Exercise testing was performed to a sign- or symptom-limited end point in 1,000 patients
(520 men, 480 women; age range 31 to 82 years) and was positive for ischemia in 13%,
negative in 64% and nondiagnostic in 23% of patients. There were no adverse effects of
exercise testing, and all patients with a negative exercise test were discharged directly from the
ED. At 30-day follow-up there was no mortality in any of the three groups. Cardiac events
in the three groups included: negative group, 1 non–Q-wave myocardial infarction (MI);
positive group, 4 non–Q-wave MIs and 12 myocardial revascularizations; nondiagnostic
group, 7 myocardial revascularizations.
CONCLUSIONS Immediate exercise testing of patients presenting to the ED with chest pain and evidence of
low clinical risk is safe and accurate for determining those who require admission and those
who can be discharged to further outpatient evaluation. (J Am Coll Cardiol 2002;40:251–6)
© 2002 by the American College of Cardiology Foundation
Safe, cost-effective management of patients presenting to
the emergency department (ED) with acute chest pain
remains a major challenge to the clinician, as reflected by
over 5 million ED visits annually in the U.S. for this
symptom (1). Over two million of these patients are
hospitalized for a possible acute coronary syndrome (ACS)
at a cost of more than $8 billion, but a cardiac etiology is
found in less than one-third of this group (2). The clini-
cian’s primary goal in patients presenting with acute chest
pain is rapid recognition and management of ACS. Sec-
ondarily, it is essential to minimize unnecessary admissions
of patients with more benign etiologies of chest pain.
However, the focus on patient safety and the litigation
potential of inadvertent discharge of patients with ACS has
resulted in a low threshold of admission for those presenting
with chest pain. Despite this cautious approach, at least 2%
of patients with acute myocardial infarction (MI) are un-
recognized at presentation and are mistakenly discharged
from the ED (3,4).
More accurate, efficient management of patients present-
ing with chest pain who are at low risk for ACS could
reduce unnecessary hospital admissions and limit costs
without compromising patient care. Studies during the past
two decades have revealed that low-risk patients can be
identified by clinical evaluation at the time of presentation
(5–7). The initial clinical assessment can detect those with
less than a 5% probability of MI (5) and those with less than
a 1% likelihood of developing major cardiac complications
(6). The ability to recognize low-risk patients has led to
alternatives to hospitalization for the traditional “rule out
MI” protocol (1,7). The most widely employed innovations
have been accelerated diagnostic protocols performed in
chest pain observation units (1,7–9). An important aspect of
this approach has been exercise testing, with or without
cardiac imaging, after ACS has been excluded. Based on the
utility of the clinical evaluation in identifying low-risk
patients (5–7), we have performed immediate treadmill
testing, without measuring serial cardiac serum markers, to
facilitate the assessment of selected patients presenting to
the ED with chest pain (10–12). However, these studies
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have included limited numbers of patients. This investiga-
tion extends our previous findings on the safety and efficacy
of immediate exercise testing to a much larger group of
low-risk patients. Some patients in this study were included
in a previous report (11).
MATERIALS AND METHODS
Patients. The study group comprised consecutive patients
who underwent immediate exercise testing if they presented
to the ED with nontraumatic chest pain of suspected
cardiac etiology but were considered to be at low clinical
risk. Chest pain varied from typical to atypical for myocar-
dial ischemia. Persistent chest pain did not preclude exercise
testing, and patients with previously documented coronary
artery disease (CAD) were not excluded. Prior evidence of
CAD was based on coronary angiography or electrocardio-
graphic (ECG) and/or serum marker criteria of MI. Criteria
of low risk included hemodynamic stability, no arrhythmia
and no evidence of an acute cardiopulmonary process on
physical examination (ECG) or chest roentgenogram. Each
patient’s coronary risk factors were assessed by history and
medical record. At the discretion of the attending physician
in the ED or in the Chest Pain Evaluation Unit, a single
cardiac serum marker (creatine kinase-MB or troponin I)
was measured in selected patients prior to the exercise test,
which was performed if the marker was negative. Inclusion
criteria were a resting ECG that was normal, had only
minor ST-T changes (0.5 mm ST depression and/or flat
but not inverted T waves) or, if abnormal, was unchanged
from a prior ECG. The presence of pathologic Q waves, if
documented to be old, did not preclude exercise testing. If
the patient presented with an abnormal ECG and no prior
ECG was available for comparison, the patient was ex-
cluded from immediate testing. Patients whose ECGs
demonstrated changes of ischemia or infarction were ex-
cluded, as were patients with repolarization changes on the
baseline ECG that precluded accurate interpretation of the
exercise ECG.
The evaluation and risk stratification of patients present-
ing to the ED with chest pain, which includes immediate
exercise testing in low-risk patients, is considered standard
of care at our institution. Approval by the University of
California-Davis, Human Subjects Review Committee was
obtained before the beginning of data collection on imme-
diate exercise testing, and a statement of exemption for this
study was subsequently granted by the Review Committee.
All data are part of our continuous quality-improvement
process.
Exercise test. All exercise tests were performed by inter-
nists who serve as attending physicians in our Chest Pain
Evaluation Unit. These physicians are not trained in emer-
gency medicine but have special training in the evaluation of
patients with chest pain and in performing and interpreting
exercise treadmill tests. We have previously reported the
comparability of these physicians to cardiologists in the
performance and interpretation of exercise tests in the ED
setting (13). Exercise testing was provided between 8:00 AM
and 8:00 PM daily. Therefore, the study group includes
patients seen during this interval who fulfilled the inclusion
criteria. The exercise test procedure has been previously
reported (10–12). Briefly, immediately after the aforemen-
tioned screening evaluation, patients were transported to the
exercise testing laboratory where a modified Bruce protocol
was employed. Exercise end points included significant
symptoms, ECG evidence of myocardial ischemia (1.0 mm
horizontal ST-segment shift at 80 ms after the J point), 10
mm Hg decrease in systolic blood pressure, coupled ven-
tricular extrasystoles or a sustained supraventricular tachy-
arrhythmia. The criteria for a positive test for ischemia were
the previously noted exercise-induced ST-segment alter-
ations. A nondiagnostic test was defined by absence of ECG
evidence of ischemia at a heart rate 85% of age-predicted
maximum.
Further evaluation. Evaluation subsequent to immediate
treadmill testing consisted of further cardiac studies and/or
clinical follow-up, which was attempted in each patient to
determine clinical status at 30 days after the immediate
treadmill test.
The predictive value of a positive exercise test was
determined by further studies in the subgroup of patients
with a positive test. These studies included coronary an-
giography, in which a significant stenosis was defined as
50% reduction in lumen diameter of a major coronary
artery; myocardial stress (exercise or pharmacologic) scin-
tigraphy by single-photon emission computed tomography
in which a positive test was a stress-induced myocardial
perfusion defect; or stress (exercise or dobutamine) echo-
cardiography, in which a positive test was a stress-induced
ventricular wall motion abnormality.
Patients with negative immediate exercise tests were
discharged from the ED with a referral for outpatient
follow-up. Patients with positive tests were admitted for
further evaluation. Depending on the individual exercise test
findings, patients with nondiagnostic tests were either
discharged from the ED or admitted to the Chest Pain
Evaluation Unit for further assessment.
Follow-up was attempted in all patients to determine
clinical status at 30 days after exercise testing by: 1) review
of the patient’s medical record; 2) telephone interviews of
the patients; 3) mailed questionnaires; 4) review of coroners’
records in Sacramento and its five surrounding counties; and
5) the Social Security Death Index.
Abbreviations and Acronyms
ACS  acute coronary syndrome
CAD  coronary artery disease
CI  confidence intervals
ECG  electrocardiogram/electrocardiographic
ED  emergency department
MI  myocardial infarction
OR  odds ratio
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Statistics. Continuous data are expressed as mean  SD
and were analyzed by Student’s t test. Ordinal data are
expressed as median. Categorical variables were analyzed by
the chi-square test. Comparisons of mean data from more
than two groups were made with the Scheffe´ F test for
multiple comparisons. Ninety-five percent confidence inter-
vals (CI) are presented for differences in means and odds
ratios (OR). Differences were considered significant if p 
0.05.
RESULTS
Study group. Between October 1993 and February 1998, a
total of 1,000 patients who presented to our ED with chest
pain met inclusion criteria for immediate exercise testing
(Table 1). The group comprised comparable numbers of
men and women. Women were slightly but significantly
older than the men, and they had a higher median number
of coronary risk factors. Previously documented CAD
confirmed by coronary angiography or MI was present in
7.5% of patients and was more frequent in men than in
women.
Exercise test. There were no adverse effects of exercise
testing. The test was negative in almost two-thirds of
patients, positive in 13%, and the remainder (23%) had a
nondiagnostic test (Fig. 1). The rate of positive tests was
similar in both men and women (11% vs. 15%, OR  0.69
[95% CI  0.69 to 1.00], p  0.06). Negative tests were
more frequent in men than in women (69% vs. 57%, OR 
1.69 [95% CI  1.3 to 2.2], p  0.001) and men had fewer
nondiagnostic tests (20% vs. 28%, OR  0.63 [95% CI 
0.47 to 0.85], p  0.003). There was no difference in the
ages of the patients in the three exercise test groups. Median
number of coronary risk factors was one in the positive and
negative groups and two in the nondiagnostic patients.
Follow-up. Based on data from the Social Security Death
Index, there was no mortality in any of the groups. Clinical
follow-up at 30 days after exercise testing was obtained in
85% of patients, including 89% with negative tests, 78% of
the nondiagnostic group and 77% with positive tests. The
group of 149 patients (15%) in whom clinical follow-up was
not obtainable did not differ from the patients with
follow-up data within their respective subgroups (negative,
positive, nondiagnostic exercise tests) with respect to age,
gender, median number of coronary risk factors, proportion
with known CAD and percent of maximum predicted heart
rate attained during exercise testing.
The group (15%) in whom clinical follow-up at 30 days
was not obtainable included 68 patients (11%) with negative
immediate exercise tests, 10 of whom underwent additional
diagnostic testing within the 30-day interval. Of the 29
patients (23%) with positive tests in whom 30-day clinical
follow-up data were unavailable, 18 had further testing. In
the 52 patients (22%) with nondiagnostic tests in whom
30-day follow-up data were unavailable, 9 had additional
testing. Therefore, clinical follow-up and/or further cardiac
testing was available within 30 days in a total of 888 patients
(89%), including 91% in the negative immediate exercise
test group, 91% in the positive group and 82% in the
nondiagnostic group (Table 2).
Negative exercise tests. The 640 patients in this group
included 363 men (57%) and 277 women (43%). Heart rate
achieved during the exercise test for the entire group was
92% of age-predicted maximum and was slightly but sig-
nificantly higher in men than in women (92% vs. 90%, p 
0.01). All patients with negative tests were discharged
directly from the ED. Of the 582 patients (91%) with
clinical follow-up or further diagnostic evaluation within 30
days, the only cardiac events were non–Q-wave MI in 1
patient and a diagnosis of CAD in another based on
myocardial stress scintigraphy (Table 2).
Positive exercise tests. Of the 125 patients with positive
tests (55 men [44%], 70 women [56%]), 102 (82%) had
further diagnostic testing, which yielded positive results in
33 (coronary angiography, 28/48; myocardial stress scintig-
raphy, 4/29; stress echocardiography 1/25) (Table 2). Based
on these findings, the positive predictive value of the initial
exercise test was 33% and was higher in men than in women
(36% vs. 19%, p  0.025). Heart rate attained during the
exercise test was 85% of predicted maximum for the total
group. This value was lower in patients with true positive
tests (80%) than with false positive tests (87%, p  0.001).
Median age was greater in patients with a true positive than
a false positive exercise test (58 11 years vs. 50 11 years,
p  0.001).
Of the 96 patients with clinical follow-up at 30 days,
Table 1. Clinical Characteristics of Patients
Men Women p Value
No. of patients 520 480
Mean age (yrs) (range) 49  12 (31–82) 52  11 (31–76) 0.001
CRF (median no.) 1 2
No. with prior CAD 47 28 0.05
CAD  coronary artery disease documented by coronary angiography or myocardial
infarction; CRF  coronary risk factors (smoking, hyperlipidemia, hypertension,
diabetes, family history of CAD).
Figure 1. Proportion of 1,000 patients with negative, positive and nondi-
agnostic immediate exercise tests. Numbers within the bars indicate
number of patients.
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cardiac events occurred in 16 (17%): non–Q-wave MI, 4
patients; myocardial revascularization, 12 patients (Table 2).
The four non–Q-wave MIs were detected by cardiac serum
injury markers in blood obtained before the exercise test and
reported after hospital admission. Evolution of the injury
markers in each of these four patients revealed a descending
pattern consistent with onset of infarction prior to the
exercise test, which did not appear to alter the pattern of
evolution. All infarctions were uncomplicated, and all four
patients underwent elective coronary angioplasty during the
hospitalization. Of the 29 patients who did not have clinical
follow-up for 30 days, 18 underwent further testing within
this interval, and it was positive in 2 (coronary angiography
1/4, stress scintigraphy 1/7, stress echocardiography 0/7).
Nondiagnostic exercise tests. This group of 235 patients
included 102 men (43%) and 133 women (57%). Further
diagnostic evaluation, performed in 79 patients (34%), was
positive for CAD or ischemia in 25 (coronary angiography
9/16, stress scintigraphy 14/44, stress echocardiography
2/19) (Table 2). Clinical follow-up for 30 days in 183
patients (78%) demonstrated no MIs during this interval.
Seven of the patients underwent elective coronary revascu-
larization (coronary angioplasty, 3; coronary artery bypass
graft surgery, 4) (Table 2).
Group mean heart rate attained during the initial exercise
test was 73% of age-predicted maximum, and this did not
differ in either men or women. Of the patients in this group,
58 (25%) reached a heart rate 80% to 84% of age-predicted
maximum, and further evaluation was positive for CAD by
coronary angiography in three patients (5%), one of whom
underwent coronary angioplasty. No MIs occurred during
the 30-day follow-up interval in this subgroup.
Comparative predictive value of immediate exercise test
results. In those patients with 30-day clinical follow-up or
a confirmatory diagnostic test during this interval, the
predictive value of the three immediate exercise test results
(positive, negative, nondiagnostic) was compared for the
total number of coronary events (mortality, MI or revascu-
larization) or diagnosis of CAD (by coronary angiography
or cardiac stress imaging). The rate of an event and/or
diagnosis of coronary disease was 29% (33/114) in the
positive group, 13% (25/192) in the nondiagnostic patients
and 0.3% (2/582) in those with negative tests. Compared to
a negative exercise test, the relative risk of a nondiagnostic
test for the aforementioned end points was 38 (95% CI  9
to 161, p 0.0001) and that of a positive test was 114 (95%
CI  27 to 484, p  0.0001).
DISCUSSION
The results of this study not only confirm our earlier reports
on the safety and utility of immediate exercise testing but
also extend them to a much larger group of low-risk patients
presenting to the ED with chest pain (10–13). The study
population was diverse and included men and women of a
wide age range extending to over 80 years. In addition, more
than 7% of patients had previously documented CAD. Of
primary importance, there were no adverse effects of exercise
testing. The major clinical advantage of this strategy has
been facilitation of appropriate discharge directly from the
ED in a majority of these patients by safe, efficient docu-
mentation of absence of exercise-induced myocardial isch-
emia. The utility of this method is further demonstrated by
the high relative risk of CAD or a coronary event in patients
with a positive immediate exercise test compared to those
with a negative or nondiagnostic result.
The majority of patients presenting to the ED with chest
pain are at relatively low risk for a coronary event, and this
group can be identified by clinical assessment at the time of
presentation (1,5–7). Clinical recognition of low risk has
provided a rationale for innovative management strategies
for these patients, thus obviating the need for traditional
hospital admission to “rule out MI.” However, because at
least 2% of patients with a coronary event are inadvertently
discharged from the ED (3,4), further assessment for an
ACS is mandatory. To this end, accelerated diagnostic
protocols are now increasingly implemented in chest-pain
observation units by a 6- to 12-h period of ECG monitoring
and serial cardiac serum markers (1,7–9). Negative results
are commonly followed by stress testing either before
patients are discharged or in the early postdischarge period.
Evaluation of low-risk patients at the time of presentation
to the ED has also been performed by myocardial scintig-
raphy in which negative results have accurately identified
those who do not require hospital admission (14). In this
Table 2. Clinical Follow-Up or Further Evaluation*†
Result of IET No. of Patients‡ Clinical Event Positive Test for CAD
Negative 582/640 (91%) 1 (MI) 1 (stress scintigraphy)
Positive 114/125 (91%) 4 (MI) 28 (coronary angiography)
12 (revascularization) 4 (stress echocardiography)
1 (stress scintigraphy)
Nondiagnostic 192/235 (82%) 7 (revascularization) 9 (coronary angiography)
14 (stress scintigraphy)
2 (stress echocardiography)
Total 888/1000 (89%)
*Within 30-day follow-up period. †Some patients had both a “clinical event” and a “positive test for CAD.” ‡Number with
clinical follow-up and/or further diagnostic evaluation of total number in group.
CAD  coronary artery disease; IET  immediate exercise test; MI  myocardial infarction.
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regard, a comparative study of low-risk patients presenting
with chest pain revealed that early treadmill exercise testing
was as informative as, and more cost-effective than, scintig-
raphy in identifying patients who did not require hospital-
ization (15). It is our experience, as well as that advocated in
the foregoing study (15), that exercise testing is suitable for
evaluation of the majority of low-risk patients presenting
with chest pain and that scintigraphy should be reserved for
the minority in whom exercise testing is not feasible (16).
In our application of immediate exercise testing, clinical
indicators of low risk have reliably identified patients who
are appropriate candidates for this approach. As reported in
our earlier studies, only a small proportion of patients had a
positive exercise test (10–12), of which slightly more than
one-third were true positives based on further evaluation.
The high rate of false positive results is typical of a low-risk
population (17). As expected, men had a higher rate of true
positive tests than women (36% vs. 19%), and patients with
a true positive result were older than those with false
positive results (58 vs. 50 years). Despite the low frequency
of true positive tests, there was a considerable gradient of
risk between the groups with the three immediate exercise
test results. The total rate of coronary events and diagnosis
of coronary disease in the negative group was only 1.0% that
of patients in the positive group and 2.3% that of patients
with nondiagnostic results.
The occurrence of only one coronary event at 30 days in
the patients with negative results confirmed the reliability of
the exercise test in predicting low short-term risk, thereby
complementing the clinical impression and permitting di-
rect discharge of these patients from the ED. It is notewor-
thy that one-fourth of patients with nondiagnostic initial
exercise tests reached a heart rate 80% to 84% of predicted
maximum, and there were no MIs or deaths in this
subgroup. This finding suggests that absence of exercise-
induced ischemia at heart rates 80% or more of predicted
maximum may be adequate for identifying low short-term
risk in patients with clinical evidence of only modest risk on
presentation. This concept requires further investigation.
Although clinical assessment is basically reliable in iden-
tifying low-risk patients with chest pain, it is imperfect and
can result in inadvertent failure to admit a small proportion
of patients with unrecognized ACS (3,4). This problem is
reflected by the inclusion of four patients with occult
non–Q-wave MIs in those we selected for immediate
exercise testing. All of these patients had positive exercise
tests, serum enzyme evidence of infarction, an uncompli-
cated course and successful myocardial revascularization. To
minimize this hazard, we now obtain one set of cardiac
injury markers prior to exercise testing. Our overall record of
safety is based upon the application of rigorous selection
criteria for exercise testing and indications for terminating
the test. In our system, internists trained in exercise testing
staff the Chest Pain Evaluation Unit and perform all
exercise tests (13). In this regard, our method differs from
that of Senaratne et al. (15), who emphasize the direct
involvement of cardiologists in the exercise test.
Study limitations. Our study has several limitations. Al-
though mortality data were available for all patients, clinical
follow-up is incomplete. However, in this large study
population, 30-day data were obtained in 85% of patients.
Further, nearly 90% of the total group had either clinical
follow-up or further diagnostic studies within 30 days.
Additionally, no differences were observed in important
clinical characteristics between the patients with and with-
out 30-day clinical follow-up. Because patients with nega-
tive and nondiagnostic exercise tests who were directly
discharged from the ED did not have serial ECGs and
cardiac serum marker testing, an ACS may not have been
recognized in some. However, the absence of mortality and
major morbidity during the follow-up period reduces this
possibility. Although the follow-up interval was only 30
days, it was our purpose to assess the utility of immediate
exercise testing in the assessment of short-term risk. This
strategy is predicated on timely patient follow-up and
further outpatient evaluation. Finally, our approach entails
the possibility of performing exercise testing in patients with
an unrecognized ACS. Although there have been no com-
plications in these patients, continued caution is a critical
element of this process.
Innovative approaches have been developed to promote
cost-effective, accurate evaluation of low-risk patients pre-
senting with acute chest pain. Application of our strategy in
a large, heterogeneous patient population has proven safe
and accurate for risk stratification, identifying those patients
who require hospital admission and those who can be safely
discharged and managed as outpatients.
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